Metabolic Activation of the Organic Fraction Coated-Onto Air Pollution PM2.5 and its Genotoxicity in a Co-Culture Model of Human Lung Cells

Article Preview

Abstract:

Air pollution Particulate Matter (PM2.5) is described as one of the major risk factors affecting human health. Hence, the objective of our research project was to evaluate the lung toxicity of PM2.5 collected in Dunkerque (France), through the study of the metabolic activation of its organic fraction (e.g. Polycyclic Aromatic Hydrocarbons, PAHs; Volatile Organic Compounds, VOCs) and its genotoxicity in two human cell models: embryonic lung epithelial L132 cells and Alveolar Macrophages (AM) isolated from bronchiolo-alveolar lavages of healthy outpatients, in mono- and/or coculture. The coculture system we used allowed the direct exposure of AM to PM2.5, and the interaction between the two cell types only through soluble factor diffusion. Exposure to Dunkerque City’s PM2.5 induced the gene expression of phase I and phase II enzymes (e.g. CYP1A1, CYP2E1, CYP2F1, NQO1, GST∏1, GSTμ3) involved in the metabolic activation of PAHS and/or VOCS, in AM, in mono- and coculture, and in L132 cells, only in monoculture. Taken together, these results reinforced the key role of AM in lung defenses, and indicated that particles, as physical vector of the penetration and retention of coated-PAHS and/or VOCS within cells, enabled them to exert a durable toxicity. DNA bulky adduct formation was also reported not only in Dunkerque City’s PM2.5-exposed AM, in mono- and coculture, but also in L132 cells from PAH-exposed coculture. Loss of Heterozygosity (LOH) and/or MicroSatellite Instability (MSI) of some MicroSatellites (MS) located in multiple critical regions of chromosome 3 were reported in L132 cells from Dunkerque City’s PM2.5-exposed mono- or cocultures.

You might also be interested in these eBooks

Info:

[1] B. Binkova, I. Chvatalova, Z. Lnenickova, A. Milcova, E. Tulupova, P.B. Farmer, R.J. Srama, PAH-DNA adducts in environmentally exposed population in relation to metabolic and DNA repair gene polymorphisms, Mutat. Res. 620 (2007) 49–61.

DOI: 10.1016/j.mrfmmm.2007.02.022

Google Scholar

[2] T. Yohena, I. Yoshino, T. Takenaka, T. Ohba, H. Kouso, A. Osoegawa, Hamatake M., Oda S., Y. Kuniyoshi, Y. Maehara, Relationship between the loss of heterozygosity and tobacco smoking in pulmonary adenocarcinoma. Oncol Res. 16(7) (2007) 333-9.

DOI: 10.3727/000000006783980982

Google Scholar

[3] F. Saint-Georges, I. Abbas, S. Billet, A. Verdin, P. Gosset, P. Mulliez, P. Shirali, G. Garçon, Gene expression induction of volatile organic compound and/or polycyclic aromatic hydrocarbon-metabolizing enzymes in isolated human alveolar macrophages in response to airborne particulate matter (PM2.5). Toxicology 244 (2008) 220-30.

DOI: 10.1016/j.tox.2007.11.016

Google Scholar

[4] S. Billet, G. Garçon, Z. Dagher, A. Verdin, F. Ledoux, D. Courcot, A. Aboukais, P. Shirali Ambient particulate matter (PM2.5): physicochemical characterization and metabolic activation of the organic fraction in human lung epithelial cells (A549). Environ. Res. 105 (2007) 212–23.

DOI: 10.1016/j.envres.2007.03.001

Google Scholar

[5] F.P. Guengerich, Separation and purification of multiple forms of microsomal cytochrome P-450, Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital- and 3-methylcholanthrene-treated rats, J Biol Chem. 253 (21)(1978) 7931-9

DOI: 10.1016/s0021-9258(17)34461-7

Google Scholar

[6] M.T. Donato, J.V. Castell, M.J. Gomez-Lechon, Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. J. Hepatol. 31 (3) (1999) 542-9.

DOI: 10.1016/s0168-8278(99)80049-x

Google Scholar

[7] K. Randerath, M.V. Reddy, R.C. Gupta, 32P-labeling test for DNA damage, Proc. Natl. Acad. Sci. USA 78 (1981) 6126–9.

DOI: 10.1073/pnas.78.10.6126

Google Scholar